Molecules, Volume 29, Issue 5
March-1 2024 - 268 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story: NK cells are highly valued in immunotherapy for their ability to rapidly kill tumor cells as well as their favorable safety profile. Their cytotoxic function is governed by a complex interplay of activating and inhibiting receptors, presenting a plethora of antigens for functional modulation via antibodies. Effective NK cell activation is attainable through the stimulation of activating receptors such as CD16, or by blocking inhibitory checkpoint molecules like TIGIT. Coupled with a binding domain for tumor-associated proteins such as B7-H3, these components can orchestrate the formation of an immunological synapse. The novel trispecific 2+1 common light chain NK cell engager B7-H3xCD16xTIGIT combines these three functionalities, facilitating potent apoptosis induction of cancer cells. View this paper